Literature DB >> 20671205

Oral and systemic health correlates of HIV-1 shedding in saliva.

M Navazesh1, R Mulligan, N Kono, S K S Kumar, M Nowicki, M Alves, W J Mack.   

Abstract

The relationship among oral and systemic health and HIV shedding in saliva is not well-understood. We hypothesized that oral and systemic health are associated with HIV shedding in saliva of HIV-infected women. Saliva from 127 participants enrolled in the Women's Interagency HIV Study (WIHS) was collected at repeated visits over a 5½-year study period (October 1998 through March 2004) and was evaluated for HIV-1 RNA. Demographic, lifestyle, and systemic and oral health characteristics were evaluated as possible correlates of salivary HIV-1 shedding. Multivariate models showed significantly increased risk of HIV-1 shedding in saliva as blood levels of CD4 cell counts decreased (p < 0.0001) and HIV RNA increased (p < 0.0001). Diabetes (p = 0.002) and a high proportion of gingival bleeding sites (p = 0.01) were associated with increased likelihood, while anti-retroviral therapy (p = 0.0003) and higher levels of stimulated saliva flow rates (p = 0.02) were associated with a lower likelihood of HIV-1 RNA shedding in saliva.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20671205      PMCID: PMC2970637          DOI: 10.1177/0022034510375290

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  31 in total

1.  Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection.

Authors:  Stephanie A Freel; Susan A Fiscus; Christopher D Pilcher; Prema Menezes; Julieta Giner; Ericka Patrick; Jeffrey L Lennox; Charles B Hicks; Joseph J Eron; Diane C Shugars
Journal:  AIDS       Date:  2003-09-26       Impact factor: 4.177

Review 2.  HIV topic update: oro-genital transmission of HIV.

Authors:  C Scully; S Porter
Journal:  Oral Dis       Date:  2000-03       Impact factor: 3.511

3.  Longitudinal variability of human immunodeficiency virus type 1 RNA viral load measurements by nucleic acid sequence-based amplification and NucliSens assays in a large multicenter study.

Authors:  M J Nowicki; L Benning; J W Bremer; W A Meyer; C Hanson; D Brambilla; S Silver; A Kovacs
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Proviral HIV-1 DNA in gingival crevicular fluid of HIV-1-infected patients in various stages of HIV disease.

Authors:  M Maticic; M Poljak; B Kramar; J Tomazic; L Vidmar; B Zakotnik; U Skaleric
Journal:  J Dent Res       Date:  2000-07       Impact factor: 6.116

5.  The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women.

Authors:  M Navazesh; R Mulligan; E Komaroff; M Redford; D Greenspan; J Phelan
Journal:  J Dent Res       Date:  2000-07       Impact factor: 6.116

6.  Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS).

Authors:  D Greenspan; E Komaroff; M Redford; J A Phelan; M Navazesh; M E Alves; H Kamrath; R Mulligan; C E Barr; J S Greenspan
Journal:  J Acquir Immune Defic Syndr       Date:  2000-09-01       Impact factor: 3.731

7.  Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva.

Authors:  D C Shugars; G D Slade; L L Patton; S A Fiscus
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2000-04

Review 8.  Saliva and inhibition of HIV-1 infection: molecular mechanisms.

Authors:  D C Shugars; S P Sweet; D Malamud; S H Kazmi; K Page-Shafer; S J Challacombe
Journal:  Oral Dis       Date:  2002       Impact factor: 3.511

9.  A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants.

Authors:  Mahvash Navazesh; Roseann Mulligan; Yolanda Barrón; Maryann Redford; Deborah Greenspan; Mario Alves; Joan Phelan
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2003-06

10.  Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS).

Authors:  M Navazesh; R Mulligan; R Karim; W J Mack; S Ram; H Seirawan; J Greenspan; D Greenspan; J Phelan; M Alves
Journal:  Oral Dis       Date:  2008-11-11       Impact factor: 3.511

View more
  3 in total

1.  Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults.

Authors:  Daniel C Beachler; Kathleen M Weber; Joseph B Margolick; Howard D Strickler; Ross D Cranston; Robert D Burk; Dorothy J Wiley; Howard Minkoff; Susheel Reddy; Emily E Stammer; Maura L Gillison; Gypsyamber D'Souza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-01       Impact factor: 4.254

2.  HIV shedding in the oral cavity: an assessment of HIV type, immunovirologic, demographic and oral factors.

Authors:  Patricia B Pavlinac; Stephen E Hawes; Geoffrey S Gottlieb; Awa Gaye; Charlotte F N'Diaye; Cathy W Critchlow; Papa Salif Sow; Qinghua Feng; Nancy B Kiviat
Journal:  Sex Transm Infect       Date:  2012-02       Impact factor: 3.519

3.  Factors contributing to salivary human immunodeficiency virus type-1 levels measured by a Poisson distribution-based PCR method.

Authors:  Ryo Ikeno; Eiko Yamada; Sayaka Yamazaki; Tomoyuki Ueda; Masaki Nagata; Ritsuo Takagi; Shingo Kato
Journal:  J Int Med Res       Date:  2017-11-09       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.